Pancreatic beta cells are specialised endocrine cells that continuously sense the levels of blood sugar and other fuels and, in response, secrete insulin to maintain normal fuel homeostasis. Glucose-induced insulin secretion and its potentiation constitute the principal mechanism of insulin release. Glucose is transported by the glucose transporter (GLUT) into the pancreatic beta-cell. Metabolism of glucose generates ATP, which inhibits ATP-sensitive K+ channels and causes voltage-dependent Ca2+ influx. Elevation of [Ca2+]i triggers exocytotic release of insulin granules. Insulin secretion is further regulated by several hormones and neurotransmitters. Peptide hormones, such as glucagon-like peptide 1 (GLP-1), increase cAMP levels and thereby potentiate insulin secretion via the combined action of PKA and Epac2. Achetylcholine (ACh), a major parasympathetic neurotransmitter, binds to Gq-coupled receptors and activates phospholipase C- (PLC-), and the stimulatory effects involve activation of protein kinase C (PKC), which stimulates exocytosis. In addition, ACh mobilizes intracellular Ca2+ by activation of IP3 receptors.

Organismal Systems; Endocrine system
BRITE hierarchy

Rousettus aegyptiacus (Egyptian rousette) [GN:ray]

PMID:20551594

Seino S, Shibasaki T, Minami K

Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.

Proc Jpn Acad Ser B Phys Biol Sci 86:563-77 (2010)
DOI:10.2183/pjab.86.563

PMID:20225132

Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ

Regulation of insulin secretion: role of mitochondrial signalling.

Diabetologia 53:1019-32 (2010)
DOI:10.1007/s00125-010-1685-0

PMID:22974438

Rorsman P, Braun M

Regulation of insulin secretion in human pancreatic islets.

Annu Rev Physiol 75:155-79 (2013)
DOI:10.1146/annurev-physiol-030212-183754

PMID:9715374

Jones PM, Persaud SJ

Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells.

Endocr Rev 19:429-61 (1998)
DOI:10.1210/edrv.19.4.0339

PMID:21934040

MacDonald PE

Signal integration at the level of ion channel and exocytotic function in pancreatic beta-cells.

Am J Physiol Endocrinol Metab 301:E1065-9 (2011)
DOI:10.1152/ajpendo.00426.2011

PMID:9914469

Lang J

Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion.

Eur J Biochem 259:3-17 (1999)
DOI:10.1046/j.1432-1327.1999.00043.x

PMID:10605628

Kieffer TJ, Habener JF

The glucagon-like peptides.

Endocr Rev 20:876-913 (1999)
DOI:10.1210/edrv.20.6.0385

PMID:19036624

Girard J

The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.

Diabetes Metab 34:550-9 (2008)
DOI:10.1016/j.diabet.2008.09.001

PMID:15655710

Holz GG

New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.

Horm Metab Res 36:787-94 (2004)
DOI:10.1055/s-2004-826165

PMID:15271645

Holst JJ, Gromada J

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.

Am J Physiol Endocrinol Metab 287:E199-206 (2004)
DOI:10.1152/ajpendo.00545.2003

PMID:17306374

Doyle ME, Egan JM

Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Pharmacol Ther 113:546-93 (2007)
DOI:10.1016/j.pharmthera.2006.11.007

PMID:19074620

Kim W, Egan JM

The role of incretins in glucose homeostasis and diabetes treatment.

Pharmacol Rev 60:470-512 (2008)
DOI:10.1124/pr.108.000604

PMID:19817800

Seino S, Takahashi H, Fujimoto W, Shibasaki T

Roles of cAMP signalling in insulin granule exocytosis.

Diabetes Obes Metab 11 Suppl 4:180-8 (2009)
DOI:10.1111/j.1463-1326.2009.01108.x

PMID:22970724

Tengholm A

Cyclic AMP dynamics in the pancreatic beta-cell.

Ups J Med Sci 117:355-69 (2012)
DOI:10.3109/03009734.2012.724732

PMID:14693691

Holz GG

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.

Diabetes 53:5-13 (2004)
DOI:10.2337/diabetes.53.1.5

PMID:20055708

Gloerich M, Bos JL

Epac: defining a new mechanism for cAMP action.

Annu Rev Pharmacol Toxicol 50:355-75 (2010)
DOI:10.1146/annurev.pharmtox.010909.105714

PMID:17084085

Bos JL

Epac proteins: multi-purpose cAMP targets.

Trends Biochem Sci 31:680-6 (2006)
DOI:10.1016/j.tibs.2006.10.002

PMID:11522660

Filipsson K, Kvist-Reimer M, Ahren B

The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.

Diabetes 50:1959-69 (2001)
DOI:10.2337/diabetes.50.9.1959

PMID:19817784

Kebede MA, Alquier T, Latour MG, Poitout V

Lipid receptors and islet function: therapeutic implications?

Diabetes Obes Metab 11 Suppl 4:10-20 (2009)
DOI:10.1111/j.1463-1326.2009.01114.x

PMID:19660440

Morgan NG, Dhayal S

G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.

Biochem Pharmacol 78:1419-27 (2009)
DOI:10.1016/j.bcp.2009.07.020